• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

Biotech firm closely linked to IU, Indiana lands huge licensing deal with Allergan

Posted on January 12, 2017 by Bill W. Hornaday

Carmel-based Assembly Biosciences Inc. — a biotech company with numerous ties to Indiana University and residents of the Hoosier State — has entered a worldwide research, development, collaboration and license agreement with Irish pharmaceutical giant Allergan Plc.

According to the Indianapolis Business Journal, the pact covers preclinical compounds for up to six gastrointestinal conditions. In turn, the deal will help Assembly develop such compounds that address ulcerative colitis, Crohn’s disease, irritable bowel syndrome and related conditions that affect millions of people.

Adam Zlotnick

The IBJ also reported that Assembly will receive an upfront payment of $50 million, plus up to $630 million in development milestone payments and up to $2.15 billion commercial milestone payments — depending on several factors such as successful clinical trials, government approval and commercial sales.

Founded in 2012, Assembly — which employs about 100 workers and consultants — is built in part around the research of Adam Zlotnick, a professor of molecular and cellular biochemistry at Indiana University Bloomington and co-founder of Assembly. By exploiting vulnerabilities in the capsid assembly of the hepatitis B virus (HBV), it is hoped that the chronic liver infection that it causes — which kills about 786,000 people annually and affects about 240 million people globally according to the Centers for Disease Control and Prevention — can be eradicated.

C. difficile is an overgrowth of bacteria in the lower gastrointestinal tract often triggered by the use of antibiotics to treat common infections. This can produce toxins that can lead to severe diarrhea, sepsis and even death. According to the CDC, deaths linked to C. difficile infections (CDI) increased more than five fold between 1999 and 2007, and C. difficile is the leading cause of death associated with gastroenteritis in the U.S. Through a unique platform for targeted delivery of beneficial bacteria, viruses, proteins and small molecules to the colon or terminal ileum, Assembly — which has research facilities in Bloomington and San Francisco — hopes to eliminate CDI as well.

Other Assembly officials with IU or Indiana ties include:

  • William W. Turner, who co-founded Assembly with Zlotnick and is a former visiting scholar in biochemistry at IU-Bloomington. Turner is head of discovery chemistry at Assembly and served for 35 years as a research chemist at Indianapolis-based Eli Lilly & Co.
  • Derek Small, a co-founder, CEO and director of Assembly, who earned a bachelors degree in business from Franklin College.
  • Richard DiMarchi, an Assembly director who is the Cox Distinguished Professor of Biochemistry and Gill Chair in Biomolecular Sciences at IU-Bloomington.
  • Micah Mackison, Assembly’s vice president of corporate development and strategy, who earned his bachelors degree in finance from IU.
  • William Ringo, an Assembly director who also serves as a director for BioCrossroads, an Indiana initiative and public-private collaboration that focuses on growing, advancing and investing in the life sciences.

Read more about Assembly’s deal with Allergan here and here.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: Alumni, Economic Development, Entrepreneurship, Faculty, International Engagement, IU Research & Technology Corporation, Research, Technology Commercialization, UncategorizedTagged Economic Development, Higher Education and Innovation, Indiana University, Innovation, Intellectual property, IU-Bloomington, Life Sciences, Small Business & Entrepreneurship, STEM (science, Technology Transfer, Workforce

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President for University Relations.

Subscribe to the Innovate Indiana Blog

Sign up to receive regular updates from Innovate Indiana Blog

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent Posts

  • IU, NSWC Crane partner on research initiative to help secure Navy's AI, machine learning systems February 1, 2023
  • IU’s, state’s participation in first-ever NBA games in India helps alumni investors score, spotlights potential economic benefits of engagement with country’s growing venture capital landscape January 31, 2023
  • IU researchers seek to commercialize AI tool to identify undiagnosed cases of early-stage Alzheimer’s disease and related dementia January 24, 2023
  • IU researchers win Translational Research grant for plastic neutron shield material technology January 20, 2023
  • IU-affiliated startup wins the Regional Pre-Seed Award from Elevate Nexus Southern Region Pitch Competition January 17, 2023

Categories

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Research
  • IU Office of the Vice President for University Relations
  • IU Ventures

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.